Results of the Web-Delphi process to YLV stakeholders (three rounds)

DOI10.5281/zenodo.5257425Zenodo5257425MaRDI QIDQ6701609FDOQ6701609

Dataset published at Zenodo repository.

Mónica Duarte Oliveira, Carlos Bana e Costa, Panos Kanavos, Aris Angelis, Klára Dimitrovová

Publication date: 25 August 2021

Copyright license: Creative Commons Attribution 4.0 International

Description

IMPACT HTA, WP7 (Methodological tools using multi-criteria value methods for HTA decision-making), Task 3 (Testing the framework with empirical applications), Results of the Web-Delphi process to TLV stakeholders (three rounds), about the views of stakeholders regarding The relevance of the following value aspects for the evaluation of new medicines in this disease context is (2020) For details on the Web-Delphi process, see: IMPACT HTA, Work Package 7 (Methodological tools using multi-criteria value methods for HTA decision-making), Task 3, Deliverable 7.3 (Testing the framework with empirical applications), Testing the IMPACT-HTA Value Framework in collaboration with HTA agencies: Case studies on Non-Small Cell Lung Cancer and Spinal Muscular Atrophy (2021), Aris Angelis (LSHTM, LSE), Mnica Oliveira (IST), Teresa Rodrigues (IST), Liliana Freitas (IST), Carlos Bana e Costa (IST), Panos Kanavos (LSE)

This page was built for dataset: Results of the Web-Delphi process to YLV stakeholders (three rounds)